There's a startling opinion piece just published in _Nature_ , made 
freely available for a week to stimulate discussion. One of its authors 
is the neuroscientist well known to psychologists, Michael Gazzaniga. The 
co-authors appear similarly eminent and well-qualified.

http://www.nature.com/nature/journal/vaop/ncurrent/full/456702a.html
 Greely, H. et al. Towards responsible use of cognitive-enhancing drugs 
by the healthy. Nature , | doi:10.1038/456702a; Published online 7 
December 2008

[BTW, if printing a pdf like this out direct from the journal produces a 
strange garble of text (mine often does) the solution is to first save to 
a file, then print].

The commentary concerns "cognitive enhancers" such as Ritalin and the 
anti-narcolepsy drug Modafinil. These drugs are currently used legally to 
treat people with ADHD and narcolepsy, and are starting to be used to 
help people with cancer-associated severe fatigue. The military also 
prescribes them to enhance alertness and performance. They are 
increasingly used illegally by college students and their professors for 
the same purpose.

The commentary makes the jaw-dropping suggestion that these drugs should 
be made legally available to healthy people for cognitive enhancement 
purposes. In their words, which they provide in italics, "We call for a 
presumption that mentally competent adults should be able to engage in 
cognitive enhancement using drugs". [I think they need a comma after 
"enhancement" to clarify what they're proposing]

Yeah, right. That's about as likely as the US legalizing marijuana any 
time soon.

Stephen
-----------------------------------------------------------------
Stephen L. Black, Ph.D.          
Professor of Psychology, Emeritus   
Bishop's University      e-mail:  [EMAIL PROTECTED]
2600 College St.
Sherbrooke QC  J1M 1Z7
Canada

Subscribe to discussion list (TIPS) for the teaching of
psychology at http://flightline.highline.edu/sfrantz/tips/
-----------------------------------------------------------------------

---
To make changes to your subscription contact:

Bill Southerly ([EMAIL PROTECTED])

Reply via email to